Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depressive Disorder, Major | 150 | 2023 | 4635 | 10.250 |
Why?
|
Antidepressive Agents | 60 | 2024 | 2837 | 5.790 |
Why?
|
S-Adenosylmethionine | 22 | 2019 | 212 | 5.250 |
Why?
|
Hypericum | 14 | 2019 | 58 | 3.880 |
Why?
|
Citalopram | 11 | 2019 | 403 | 3.190 |
Why?
|
Depression | 62 | 2024 | 7760 | 3.000 |
Why?
|
Eicosapentaenoic Acid | 12 | 2023 | 581 | 2.340 |
Why?
|
Fatty Acids, Omega-3 | 22 | 2023 | 1344 | 2.290 |
Why?
|
Depressive Disorder | 22 | 2024 | 3744 | 2.220 |
Why?
|
Phytotherapy | 10 | 2013 | 298 | 2.120 |
Why?
|
Complementary Therapies | 10 | 2020 | 485 | 1.880 |
Why?
|
Antidepressive Agents, Second-Generation | 16 | 2015 | 503 | 1.830 |
Why?
|
Docosahexaenoic Acids | 10 | 2023 | 877 | 1.810 |
Why?
|
Yoga | 6 | 2023 | 252 | 1.710 |
Why?
|
Double-Blind Method | 64 | 2024 | 12020 | 1.630 |
Why?
|
Suicide, Attempted | 17 | 2021 | 1218 | 1.620 |
Why?
|
Sleep Initiation and Maintenance Disorders | 8 | 2022 | 1004 | 1.570 |
Why?
|
Fluoxetine | 20 | 2012 | 749 | 1.560 |
Why?
|
Piperazines | 13 | 2017 | 2487 | 1.480 |
Why?
|
Dietary Supplements | 21 | 2024 | 3292 | 1.440 |
Why?
|
Acupuncture Therapy | 6 | 2015 | 464 | 1.390 |
Why?
|
Suicidal Ideation | 17 | 2021 | 1246 | 1.360 |
Why?
|
Sertraline | 4 | 2016 | 206 | 1.350 |
Why?
|
Psychiatric Status Rating Scales | 42 | 2019 | 6030 | 1.250 |
Why?
|
Plant Extracts | 7 | 2014 | 471 | 1.120 |
Why?
|
Folic Acid | 11 | 2016 | 1293 | 1.100 |
Why?
|
Antipsychotic Agents | 11 | 2019 | 3057 | 1.090 |
Why?
|
Quinolones | 4 | 2013 | 368 | 1.080 |
Why?
|
Ketamine | 6 | 2022 | 501 | 1.020 |
Why?
|
Libido | 4 | 2013 | 114 | 0.990 |
Why?
|
Mental Disorders | 18 | 2023 | 6593 | 0.900 |
Why?
|
Republic of Korea | 23 | 2022 | 538 | 0.870 |
Why?
|
Brain-Derived Neurotrophic Factor | 7 | 2023 | 604 | 0.850 |
Why?
|
Electroacupuncture | 1 | 2022 | 60 | 0.830 |
Why?
|
Interview, Psychological | 3 | 2017 | 812 | 0.800 |
Why?
|
Personality Disorders | 6 | 2020 | 713 | 0.790 |
Why?
|
Dependent Personality Disorder | 1 | 2020 | 13 | 0.770 |
Why?
|
Treatment Outcome | 81 | 2022 | 63042 | 0.770 |
Why?
|
Placebos | 9 | 2019 | 1674 | 0.750 |
Why?
|
Randomized Controlled Trials as Topic | 19 | 2024 | 9944 | 0.740 |
Why?
|
Lepidium | 2 | 2011 | 7 | 0.740 |
Why?
|
Middle Aged | 134 | 2023 | 213241 | 0.730 |
Why?
|
Humans | 261 | 2024 | 743811 | 0.720 |
Why?
|
Independent Living | 3 | 2021 | 569 | 0.720 |
Why?
|
Adult | 139 | 2023 | 213889 | 0.710 |
Why?
|
Sexual Dysfunction, Physiological | 4 | 2013 | 355 | 0.710 |
Why?
|
Mitragyna | 1 | 2019 | 15 | 0.700 |
Why?
|
Female | 175 | 2024 | 380020 | 0.690 |
Why?
|
Male | 163 | 2024 | 349776 | 0.690 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 11 | 2013 | 1951 | 0.660 |
Why?
|
Drug Resistance | 8 | 2013 | 1606 | 0.650 |
Why?
|
Akathisia, Drug-Induced | 2 | 2017 | 67 | 0.640 |
Why?
|
Bipolar Disorder | 9 | 2020 | 5027 | 0.640 |
Why?
|
Drug Therapy, Combination | 25 | 2020 | 6487 | 0.640 |
Why?
|
Psychotic Disorders | 7 | 2020 | 3044 | 0.630 |
Why?
|
Riluzole | 2 | 2019 | 55 | 0.610 |
Why?
|
Cannabidiol | 1 | 2019 | 106 | 0.600 |
Why?
|
Pilot Projects | 18 | 2023 | 8316 | 0.590 |
Why?
|
Psychiatry | 9 | 2023 | 1694 | 0.580 |
Why?
|
Personality | 1 | 2020 | 552 | 0.580 |
Why?
|
Folic Acid Deficiency | 4 | 2009 | 115 | 0.570 |
Why?
|
Military Personnel | 2 | 2019 | 1133 | 0.570 |
Why?
|
Thiazoles | 4 | 2017 | 1482 | 0.570 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2017 | 166 | 0.560 |
Why?
|
Panic Disorder | 4 | 2020 | 616 | 0.540 |
Why?
|
Dose-Response Relationship, Drug | 20 | 2020 | 10940 | 0.520 |
Why?
|
Psychotherapy | 8 | 2020 | 1640 | 0.520 |
Why?
|
Dementia | 4 | 2022 | 2518 | 0.520 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2020 | 449 | 0.520 |
Why?
|
Quality of Life | 8 | 2022 | 12788 | 0.500 |
Why?
|
Anxiety | 13 | 2022 | 4288 | 0.500 |
Why?
|
Naltrexone | 1 | 2016 | 307 | 0.480 |
Why?
|
Suicide | 8 | 2017 | 1476 | 0.480 |
Why?
|
Hospitals, General | 6 | 2023 | 749 | 0.470 |
Why?
|
Plant Preparations | 2 | 2011 | 94 | 0.460 |
Why?
|
Psychological Techniques | 1 | 2013 | 45 | 0.460 |
Why?
|
Hot Temperature | 1 | 2019 | 1351 | 0.450 |
Why?
|
Carnitine | 1 | 2014 | 245 | 0.440 |
Why?
|
Behavior, Addictive | 4 | 2021 | 462 | 0.430 |
Why?
|
Patient Selection | 3 | 2017 | 4210 | 0.430 |
Why?
|
Young Adult | 44 | 2022 | 56392 | 0.430 |
Why?
|
Taurine | 1 | 2012 | 94 | 0.430 |
Why?
|
Histamine | 1 | 2014 | 507 | 0.420 |
Why?
|
Dysthymic Disorder | 1 | 2011 | 74 | 0.400 |
Why?
|
Anger | 5 | 2020 | 401 | 0.390 |
Why?
|
Vitamin D | 5 | 2023 | 3222 | 0.380 |
Why?
|
Dissociative Disorders | 1 | 2013 | 231 | 0.380 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2012 | 284 | 0.380 |
Why?
|
Amnesia | 1 | 2013 | 248 | 0.380 |
Why?
|
Cholecalciferol | 4 | 2024 | 536 | 0.380 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 216 | 0.370 |
Why?
|
Hallucinations | 1 | 2013 | 358 | 0.370 |
Why?
|
Sulfones | 1 | 2013 | 434 | 0.370 |
Why?
|
Homocysteine | 6 | 2012 | 647 | 0.360 |
Why?
|
Acetylcysteine | 1 | 2011 | 271 | 0.360 |
Why?
|
Seasonal Affective Disorder | 1 | 2009 | 50 | 0.350 |
Why?
|
Clinical Trials as Topic | 7 | 2017 | 7908 | 0.350 |
Why?
|
Aged | 57 | 2024 | 163178 | 0.350 |
Why?
|
Academies and Institutes | 1 | 2012 | 317 | 0.350 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 605 | 0.350 |
Why?
|
Pregnanolone | 2 | 2020 | 62 | 0.350 |
Why?
|
Telomere | 4 | 2021 | 910 | 0.340 |
Why?
|
Sexual Dysfunctions, Psychological | 3 | 2018 | 182 | 0.330 |
Why?
|
Depression, Postpartum | 3 | 2022 | 340 | 0.320 |
Why?
|
Weight Gain | 3 | 2017 | 2294 | 0.320 |
Why?
|
Placebo Effect | 2 | 2017 | 503 | 0.320 |
Why?
|
Anxiety Disorders | 9 | 2021 | 2684 | 0.320 |
Why?
|
Carbonated Beverages | 1 | 2009 | 213 | 0.320 |
Why?
|
Behavioral Symptoms | 1 | 2010 | 175 | 0.320 |
Why?
|
Pharmacogenetics | 1 | 2012 | 674 | 0.310 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1148 | 0.310 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 3839 | 0.310 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2011 | 3070 | 0.310 |
Why?
|
Infrared Rays | 2 | 2019 | 249 | 0.310 |
Why?
|
Triazoles | 2 | 2004 | 904 | 0.300 |
Why?
|
Medical History Taking | 1 | 2011 | 782 | 0.300 |
Why?
|
Combined Modality Therapy | 7 | 2018 | 8637 | 0.300 |
Why?
|
Interleukin-6 | 4 | 2022 | 3208 | 0.290 |
Why?
|
Tetrahydrofolates | 3 | 2012 | 60 | 0.290 |
Why?
|
Students | 2 | 2015 | 1647 | 0.290 |
Why?
|
Alcoholism | 2 | 2017 | 1907 | 0.280 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2019 | 4266 | 0.280 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2018 | 632 | 0.280 |
Why?
|
Sexual Behavior | 3 | 2023 | 2049 | 0.280 |
Why?
|
Inflammation | 6 | 2023 | 10629 | 0.280 |
Why?
|
Tachyphylaxis | 2 | 2018 | 51 | 0.270 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4422 | 0.270 |
Why?
|
Adolescent | 41 | 2023 | 85729 | 0.260 |
Why?
|
Veterans | 1 | 2019 | 2519 | 0.260 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 200 | 0.260 |
Why?
|
Thiazepines | 2 | 2015 | 30 | 0.250 |
Why?
|
Patients | 1 | 2011 | 899 | 0.250 |
Why?
|
Electrocardiography | 2 | 2022 | 6441 | 0.250 |
Why?
|
Vitamin B 12 | 5 | 2012 | 527 | 0.250 |
Why?
|
Affect | 3 | 2021 | 1473 | 0.250 |
Why?
|
Sex Characteristics | 1 | 2015 | 2583 | 0.250 |
Why?
|
Polymorphism, Genetic | 3 | 2018 | 4326 | 0.240 |
Why?
|
Food | 1 | 2009 | 771 | 0.240 |
Why?
|
Personality Inventory | 5 | 2019 | 1030 | 0.240 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 906 | 0.240 |
Why?
|
Personality Assessment | 3 | 2020 | 647 | 0.240 |
Why?
|
Psychoanalytic Interpretation | 1 | 2004 | 57 | 0.240 |
Why?
|
Ambulatory Care | 3 | 2014 | 2707 | 0.230 |
Why?
|
Bupropion | 3 | 2006 | 303 | 0.230 |
Why?
|
DNA Methylation | 4 | 2023 | 4286 | 0.220 |
Why?
|
Cross-Cultural Comparison | 3 | 2016 | 651 | 0.220 |
Why?
|
Biological Psychiatry | 1 | 2022 | 25 | 0.210 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 201 | 0.210 |
Why?
|
Receptors, Dopamine | 1 | 2002 | 295 | 0.210 |
Why?
|
Obsessive Behavior | 1 | 2021 | 47 | 0.200 |
Why?
|
Treatment Failure | 3 | 2021 | 2617 | 0.200 |
Why?
|
Vitamins | 5 | 2023 | 1622 | 0.200 |
Why?
|
Impulsive Behavior | 3 | 2019 | 316 | 0.200 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2760 | 0.190 |
Why?
|
Hostility | 2 | 2013 | 189 | 0.190 |
Why?
|
Leptin | 3 | 2019 | 1600 | 0.190 |
Why?
|
Outpatients | 6 | 2020 | 1488 | 0.190 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 1937 | 0.190 |
Why?
|
C-Reactive Protein | 4 | 2023 | 3778 | 0.190 |
Why?
|
Cognition | 6 | 2024 | 6759 | 0.190 |
Why?
|
Compulsive Behavior | 1 | 2021 | 116 | 0.190 |
Why?
|
Heterosexuality | 1 | 2023 | 275 | 0.190 |
Why?
|
Heating | 1 | 2021 | 97 | 0.190 |
Why?
|
Anemia, Macrocytic | 1 | 2000 | 55 | 0.190 |
Why?
|
Psychopharmacology | 2 | 2019 | 143 | 0.190 |
Why?
|
Hallucinogens | 1 | 2023 | 177 | 0.180 |
Why?
|
Menarche | 1 | 2023 | 516 | 0.180 |
Why?
|
Paranoid Behavior | 1 | 2019 | 5 | 0.180 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 668 | 0.180 |
Why?
|
Panic | 1 | 2019 | 105 | 0.180 |
Why?
|
Plant Roots | 2 | 2011 | 109 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2002 | 1143 | 0.170 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2000 | 116 | 0.170 |
Why?
|
Herpes Simplex | 1 | 2023 | 470 | 0.170 |
Why?
|
Luteal Phase | 1 | 2019 | 147 | 0.170 |
Why?
|
Follicular Phase | 1 | 2019 | 152 | 0.170 |
Why?
|
Sleep | 4 | 2021 | 4619 | 0.170 |
Why?
|
Personal Satisfaction | 2 | 2016 | 641 | 0.170 |
Why?
|
Methionine | 2 | 2012 | 590 | 0.160 |
Why?
|
Thinking | 1 | 2021 | 317 | 0.160 |
Why?
|
Administration, Intranasal | 1 | 2020 | 446 | 0.160 |
Why?
|
Sleep, REM | 1 | 2022 | 592 | 0.160 |
Why?
|
Drug Synergism | 4 | 2017 | 1794 | 0.160 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 815 | 0.160 |
Why?
|
Analysis of Variance | 6 | 2016 | 6356 | 0.160 |
Why?
|
Globus Pallidus | 1 | 2019 | 253 | 0.160 |
Why?
|
Breathing Exercises | 1 | 2018 | 53 | 0.150 |
Why?
|
Sleep Stages | 1 | 2022 | 685 | 0.150 |
Why?
|
Canada | 2 | 2022 | 2064 | 0.150 |
Why?
|
Pituitary-Adrenal System | 2 | 2018 | 553 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 28 | 0.150 |
Why?
|
Comorbidity | 10 | 2018 | 10380 | 0.150 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2015 | 370 | 0.150 |
Why?
|
Psychometrics | 5 | 2022 | 3000 | 0.150 |
Why?
|
Primary Health Care | 6 | 2023 | 4556 | 0.150 |
Why?
|
Progesterone | 2 | 2019 | 773 | 0.150 |
Why?
|
Tobacco Use Cessation | 1 | 2018 | 95 | 0.150 |
Why?
|
Body Weight | 3 | 2022 | 4670 | 0.150 |
Why?
|
Diet | 3 | 2021 | 7930 | 0.140 |
Why?
|
Meditation | 3 | 2020 | 240 | 0.140 |
Why?
|
Cyclohexanols | 2 | 2009 | 127 | 0.140 |
Why?
|
Antimanic Agents | 3 | 2020 | 522 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2018 | 703 | 0.140 |
Why?
|
Time Factors | 11 | 2021 | 40038 | 0.140 |
Why?
|
Follow-Up Studies | 15 | 2020 | 39001 | 0.140 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 648 | 0.140 |
Why?
|
Electroconvulsive Therapy | 1 | 2021 | 477 | 0.140 |
Why?
|
Physicians | 1 | 2014 | 4569 | 0.140 |
Why?
|
Nicotinic Agonists | 1 | 2018 | 271 | 0.140 |
Why?
|
Hypochondriasis | 1 | 2016 | 92 | 0.140 |
Why?
|
Testosterone | 2 | 2020 | 2297 | 0.140 |
Why?
|
Bulimia | 1 | 2018 | 383 | 0.140 |
Why?
|
Thalamus | 2 | 2017 | 1023 | 0.140 |
Why?
|
Secondary Prevention | 3 | 2011 | 1529 | 0.130 |
Why?
|
Internship and Residency | 4 | 2020 | 5787 | 0.130 |
Why?
|
Cohort Studies | 9 | 2022 | 40545 | 0.130 |
Why?
|
Paraquat | 1 | 2015 | 34 | 0.130 |
Why?
|
Menopause | 2 | 2023 | 1626 | 0.130 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 25032 | 0.130 |
Why?
|
Brain | 5 | 2019 | 26345 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.130 |
Why?
|
Aging | 4 | 2023 | 8655 | 0.130 |
Why?
|
Education, Medical, Graduate | 1 | 2007 | 2291 | 0.130 |
Why?
|
Video Games | 1 | 2017 | 184 | 0.130 |
Why?
|
Prevalence | 7 | 2019 | 15211 | 0.130 |
Why?
|
Railroads | 1 | 2014 | 61 | 0.130 |
Why?
|
Water | 1 | 2021 | 1394 | 0.130 |
Why?
|
Nerve Net | 2 | 2017 | 2173 | 0.120 |
Why?
|
Herbicides | 1 | 2015 | 100 | 0.120 |
Why?
|
Prefrontal Cortex | 3 | 2022 | 2147 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 522 | 0.120 |
Why?
|
Epigenesis, Genetic | 4 | 2023 | 3645 | 0.120 |
Why?
|
Epidermal Growth Factor | 4 | 1995 | 709 | 0.120 |
Why?
|
Risk Factors | 18 | 2023 | 72252 | 0.120 |
Why?
|
Triazines | 1 | 2016 | 315 | 0.120 |
Why?
|
Massachusetts | 6 | 2020 | 8660 | 0.120 |
Why?
|
Heart Rate | 3 | 2022 | 4091 | 0.120 |
Why?
|
Infusions, Intravenous | 4 | 2022 | 2274 | 0.120 |
Why?
|
Leucovorin | 2 | 2009 | 628 | 0.120 |
Why?
|
Psychomotor Agitation | 2 | 2014 | 293 | 0.120 |
Why?
|
United States | 13 | 2022 | 69859 | 0.120 |
Why?
|
Thyroidectomy | 1 | 2019 | 879 | 0.120 |
Why?
|
Employment | 1 | 2020 | 1132 | 0.120 |
Why?
|
Accidents | 1 | 2014 | 164 | 0.120 |
Why?
|
Somatoform Disorders | 2 | 2008 | 423 | 0.120 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 297 | 0.110 |
Why?
|
Caregivers | 2 | 2022 | 2098 | 0.110 |
Why?
|
Mental Health Services | 2 | 2004 | 1643 | 0.110 |
Why?
|
Nicotine | 1 | 2018 | 681 | 0.110 |
Why?
|
Remission Induction | 4 | 2016 | 2384 | 0.110 |
Why?
|
Psychiatric Department, Hospital | 2 | 2007 | 135 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2020 | 1828 | 0.110 |
Why?
|
Transforming Growth Factors | 1 | 1992 | 76 | 0.110 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2401 | 0.110 |
Why?
|
Phototherapy | 2 | 2020 | 377 | 0.110 |
Why?
|
Case-Control Studies | 7 | 2019 | 21733 | 0.110 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4931 | 0.110 |
Why?
|
S-Adenosylhomocysteine | 1 | 2012 | 41 | 0.110 |
Why?
|
Patient Dropouts | 2 | 2012 | 420 | 0.100 |
Why?
|
Recurrence | 4 | 2020 | 8337 | 0.100 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2012 | 295 | 0.100 |
Why?
|
Life Style | 2 | 2021 | 3833 | 0.100 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2013 | 101 | 0.100 |
Why?
|
Severity of Illness Index | 10 | 2019 | 15526 | 0.100 |
Why?
|
Aminopyridines | 1 | 2015 | 543 | 0.100 |
Why?
|
Referral and Consultation | 3 | 2023 | 3530 | 0.100 |
Why?
|
Integrative Medicine | 1 | 2013 | 87 | 0.100 |
Why?
|
Acupuncture Points | 1 | 2012 | 101 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8035 | 0.100 |
Why?
|
Liver Regeneration | 2 | 1995 | 211 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 397 | 0.100 |
Why?
|
Resilience, Psychological | 1 | 2019 | 677 | 0.100 |
Why?
|
Probability | 3 | 2013 | 2505 | 0.100 |
Why?
|
Cognition Disorders | 3 | 2011 | 4041 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 2883 | 0.100 |
Why?
|
Universities | 2 | 2015 | 951 | 0.100 |
Why?
|
Follicle Stimulating Hormone | 1 | 2013 | 745 | 0.100 |
Why?
|
Boston | 3 | 2019 | 9310 | 0.100 |
Why?
|
Penile Erection | 1 | 2011 | 89 | 0.100 |
Why?
|
Rhodiola | 1 | 2010 | 4 | 0.100 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1992 | 440 | 0.100 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2010 | 50 | 0.100 |
Why?
|
Anti-Anxiety Agents | 1 | 2013 | 390 | 0.100 |
Why?
|
5-Hydroxytryptophan | 1 | 2010 | 32 | 0.090 |
Why?
|
Thyrotropin | 1 | 2014 | 850 | 0.090 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.090 |
Why?
|
Serotonin | 3 | 2023 | 1017 | 0.090 |
Why?
|
Lipids | 2 | 2014 | 3307 | 0.090 |
Why?
|
Azabicyclo Compounds | 1 | 2010 | 68 | 0.090 |
Why?
|
Liver | 4 | 1995 | 7479 | 0.090 |
Why?
|
Acculturation | 1 | 2012 | 182 | 0.090 |
Why?
|
Light | 1 | 2016 | 1365 | 0.090 |
Why?
|
Herbal Medicine | 1 | 2010 | 37 | 0.090 |
Why?
|
Internet | 3 | 2017 | 3058 | 0.090 |
Why?
|
Telomerase | 1 | 2015 | 731 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3275 | 0.090 |
Why?
|
Research | 1 | 2018 | 1999 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2013 | 1586 | 0.090 |
Why?
|
Chromium | 1 | 2010 | 123 | 0.090 |
Why?
|
Eligibility Determination | 1 | 2013 | 404 | 0.090 |
Why?
|
Purines | 1 | 2013 | 590 | 0.090 |
Why?
|
Pyrrolidines | 1 | 2011 | 341 | 0.090 |
Why?
|
Life Change Events | 1 | 2014 | 938 | 0.090 |
Why?
|
Inositol | 1 | 2010 | 218 | 0.090 |
Why?
|
Dosage Forms | 1 | 2009 | 56 | 0.080 |
Why?
|
Triiodothyronine | 2 | 2014 | 494 | 0.080 |
Why?
|
Binge-Eating Disorder | 1 | 2010 | 137 | 0.080 |
Why?
|
Cross-Over Studies | 2 | 2016 | 2029 | 0.080 |
Why?
|
Bulimia Nervosa | 1 | 2010 | 177 | 0.080 |
Why?
|
Pain Measurement | 1 | 2018 | 3420 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1060 | 0.080 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2012 | 260 | 0.080 |
Why?
|
Hormones | 2 | 2023 | 889 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2018 | 1342 | 0.080 |
Why?
|
Hydrocortisone | 3 | 2020 | 1826 | 0.080 |
Why?
|
Cost of Illness | 2 | 2020 | 1859 | 0.080 |
Why?
|
Self Concept | 1 | 2014 | 1024 | 0.080 |
Why?
|
Glycine | 1 | 2011 | 670 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3155 | 0.080 |
Why?
|
Violence | 1 | 2014 | 909 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 277 | 0.080 |
Why?
|
Fatigue | 1 | 2015 | 1530 | 0.080 |
Why?
|
Personal Autonomy | 1 | 2010 | 298 | 0.080 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2008 | 361 | 0.080 |
Why?
|
Social Adjustment | 1 | 2010 | 629 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2022 | 3921 | 0.070 |
Why?
|
Perceptual Distortion | 1 | 2007 | 35 | 0.070 |
Why?
|
Prolactin | 2 | 2013 | 668 | 0.070 |
Why?
|
Pregnancy | 6 | 2023 | 29140 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 1676 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6259 | 0.070 |
Why?
|
Neurotransmitter Agents | 1 | 2010 | 646 | 0.070 |
Why?
|
Models, Statistical | 2 | 2012 | 5100 | 0.070 |
Why?
|
Transforming Growth Factor beta | 3 | 1995 | 2006 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1619 | 0.070 |
Why?
|
Exercise Therapy | 1 | 2013 | 904 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19894 | 0.070 |
Why?
|
Quinolines | 1 | 2011 | 732 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 950 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 896 | 0.070 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1660 | 0.070 |
Why?
|
Advisory Committees | 1 | 2010 | 775 | 0.070 |
Why?
|
Australia | 2 | 2019 | 1167 | 0.070 |
Why?
|
Child Abuse | 1 | 2014 | 1030 | 0.070 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3608 | 0.070 |
Why?
|
Attitude to Health | 2 | 2013 | 2052 | 0.070 |
Why?
|
Patient Preference | 1 | 2013 | 889 | 0.070 |
Why?
|
Regression Analysis | 4 | 2014 | 6457 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2620 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1503 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1813 | 0.060 |
Why?
|
Cholesterol | 2 | 2004 | 2922 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2739 | 0.060 |
Why?
|
Polysomnography | 2 | 2022 | 1776 | 0.060 |
Why?
|
Lithium | 3 | 2004 | 601 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 1995 | 5854 | 0.060 |
Why?
|
Prospective Studies | 5 | 2019 | 53250 | 0.060 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2023 | 46 | 0.060 |
Why?
|
Philosophy | 1 | 2004 | 66 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57744 | 0.060 |
Why?
|
Stress, Psychological | 3 | 2014 | 4245 | 0.060 |
Why?
|
Culture | 3 | 2007 | 632 | 0.060 |
Why?
|
Postpartum Period | 2 | 2022 | 1086 | 0.050 |
Why?
|
Psychoneuroimmunology | 1 | 2022 | 13 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1395 | 0.050 |
Why?
|
Euphoria | 1 | 2022 | 67 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 1161 | 0.050 |
Why?
|
Pirenzepine | 1 | 2002 | 115 | 0.050 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2002 | 33 | 0.050 |
Why?
|
Research Design | 2 | 2020 | 5983 | 0.050 |
Why?
|
Androgens | 1 | 2009 | 1247 | 0.050 |
Why?
|
Leukocytes | 2 | 2023 | 2044 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2014 | 434 | 0.050 |
Why?
|
Anorexia Nervosa | 1 | 2010 | 1286 | 0.050 |
Why?
|
Social Behavior | 1 | 2008 | 1126 | 0.050 |
Why?
|
Attitude | 1 | 2007 | 775 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 1995 | 9648 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7324 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2023 | 189 | 0.050 |
Why?
|
Gyrus Cinguli | 2 | 2020 | 1091 | 0.050 |
Why?
|
Technology | 1 | 2023 | 302 | 0.050 |
Why?
|
Thiophenes | 1 | 2006 | 589 | 0.050 |
Why?
|
Social Perception | 1 | 2004 | 425 | 0.050 |
Why?
|
Japan | 2 | 2015 | 1360 | 0.050 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
Systems Analysis | 1 | 2021 | 171 | 0.050 |
Why?
|
Receptors, Interleukin-6 | 1 | 2022 | 225 | 0.050 |
Why?
|
Health Surveys | 2 | 2021 | 4036 | 0.050 |
Why?
|
RNA, Messenger | 2 | 1992 | 13028 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13404 | 0.050 |
Why?
|
Religion | 1 | 2004 | 356 | 0.050 |
Why?
|
Erythrocyte Count | 1 | 2000 | 163 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 6976 | 0.050 |
Why?
|
Fatty Acids | 1 | 2008 | 1809 | 0.050 |
Why?
|
Data Collection | 2 | 2007 | 3339 | 0.050 |
Why?
|
Physician's Role | 1 | 2007 | 942 | 0.050 |
Why?
|
GABA Modulators | 1 | 2020 | 107 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 77410 | 0.040 |
Why?
|
Chronic Disease | 2 | 2020 | 9139 | 0.040 |
Why?
|
Calcium Phosphates | 1 | 2020 | 170 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2071 | 0.040 |
Why?
|
Incidence | 4 | 2022 | 20948 | 0.040 |
Why?
|
Spirituality | 1 | 2004 | 405 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1460 | 0.040 |
Why?
|
Irritable Mood | 1 | 2020 | 183 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2000 | 376 | 0.040 |
Why?
|
Psychopathology | 1 | 2021 | 407 | 0.040 |
Why?
|
Empathy | 1 | 2023 | 474 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2007 | 1077 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2483 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 476 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12954 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3020 | 0.040 |
Why?
|
Ovariectomy | 1 | 2021 | 661 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1436 | 0.040 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 442 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15518 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1030 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 1995 | 287 | 0.040 |
Why?
|
Zinc | 1 | 2022 | 683 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 387 | 0.040 |
Why?
|
Mood Disorders | 1 | 2004 | 1104 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 29052 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15281 | 0.040 |
Why?
|
Mental Health | 2 | 2018 | 3012 | 0.040 |
Why?
|
Delphi Technique | 1 | 2020 | 777 | 0.040 |
Why?
|
Professional Competence | 1 | 2000 | 447 | 0.040 |
Why?
|
Cell Adhesion | 2 | 1994 | 3144 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 546 | 0.040 |
Why?
|
Genetic Markers | 1 | 2023 | 2634 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2004 | 941 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1340 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.030 |
Why?
|
Color | 1 | 2016 | 304 | 0.030 |
Why?
|
Politics | 1 | 2022 | 791 | 0.030 |
Why?
|
Child | 6 | 2023 | 77637 | 0.030 |
Why?
|
Basement Membrane | 2 | 1994 | 357 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1424 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2020 | 719 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2015 | 162 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1104 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2016 | 626 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1358 | 0.030 |
Why?
|
Age Factors | 3 | 2023 | 18355 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 659 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2429 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6061 | 0.030 |
Why?
|
G1 Phase | 1 | 1995 | 415 | 0.030 |
Why?
|
Curriculum | 1 | 2007 | 3603 | 0.030 |
Why?
|
Netherlands | 1 | 2018 | 2170 | 0.030 |
Why?
|
Desipramine | 2 | 2004 | 184 | 0.030 |
Why?
|
Sex Offenses | 1 | 2018 | 354 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2419 | 0.030 |
Why?
|
Binding Sites | 1 | 2002 | 6111 | 0.030 |
Why?
|
Exercise | 2 | 2020 | 5611 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2018 | 671 | 0.030 |
Why?
|
Sex Distribution | 2 | 2013 | 2298 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1101 | 0.030 |
Why?
|
Body Temperature | 1 | 2016 | 774 | 0.030 |
Why?
|
Punishment | 1 | 2014 | 98 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2004 | 7784 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2019 | 3503 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1433 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3769 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2453 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 1992 | 194 | 0.030 |
Why?
|
Cycloheximide | 1 | 1992 | 347 | 0.030 |
Why?
|
Alcohol Drinking | 2 | 2020 | 3965 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 35409 | 0.030 |
Why?
|
Adolescent Psychiatry | 1 | 2013 | 148 | 0.030 |
Why?
|
Education, Medical | 1 | 2004 | 1722 | 0.030 |
Why?
|
Inpatients | 1 | 2023 | 2515 | 0.030 |
Why?
|
Clinical Competence | 1 | 2007 | 4687 | 0.020 |
Why?
|
Gels | 1 | 1992 | 425 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2656 | 0.020 |
Why?
|
Postmenopause | 1 | 2020 | 2458 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 7729 | 0.020 |
Why?
|
Melatonin | 1 | 2016 | 721 | 0.020 |
Why?
|
Government Regulation | 1 | 2015 | 522 | 0.020 |
Why?
|
Thyroxine | 1 | 2014 | 667 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 2954 | 0.020 |
Why?
|
Child Psychiatry | 1 | 2013 | 220 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4463 | 0.020 |
Why?
|
Self Report | 2 | 2012 | 3550 | 0.020 |
Why?
|
Cells, Cultured | 4 | 1995 | 19232 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 5021 | 0.020 |
Why?
|
Reaction Time | 1 | 2016 | 2091 | 0.020 |
Why?
|
Minerals | 1 | 2011 | 267 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15067 | 0.020 |
Why?
|
Health Personnel | 2 | 2004 | 3217 | 0.020 |
Why?
|
Animals | 8 | 2020 | 168660 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3000 | 0.020 |
Why?
|
Rats | 4 | 1995 | 24250 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3082 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10394 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12944 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2009 | 916 | 0.020 |
Why?
|
Hepatectomy | 1 | 1992 | 550 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4974 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2614 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6188 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
Cell Division | 2 | 1994 | 4568 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2020 | 1796 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 1995 | 8300 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4221 | 0.020 |
Why?
|
Corpus Striatum | 1 | 2014 | 1219 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7150 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2009 | 710 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.020 |
Why?
|
Executive Function | 1 | 2016 | 1361 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1813 | 0.020 |
Why?
|
Constipation | 1 | 2012 | 546 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 841 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1994 | 1743 | 0.020 |
Why?
|
Psychology | 1 | 2008 | 356 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2393 | 0.020 |
Why?
|
Estradiol | 1 | 2013 | 2017 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2453 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 688 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8551 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1733 | 0.020 |
Why?
|
Transcription Factors | 2 | 1995 | 12209 | 0.020 |
Why?
|
Mental Recall | 1 | 2011 | 1206 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2354 | 0.020 |
Why?
|
Motivation | 1 | 2014 | 1971 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3480 | 0.010 |
Why?
|
Blood Platelets | 1 | 2014 | 2509 | 0.010 |
Why?
|
Fenfluramine | 1 | 2003 | 59 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2006 | 676 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3320 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12718 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 606 | 0.010 |
Why?
|
Trazodone | 1 | 2002 | 66 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25609 | 0.010 |
Why?
|
Endpoint Determination | 1 | 2005 | 601 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13980 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2327 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9677 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 322 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1171 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5952 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6565 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9848 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2004 | 402 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7295 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3750 | 0.010 |
Why?
|
Brain Mapping | 1 | 2016 | 6622 | 0.010 |
Why?
|
Creatinine | 1 | 2005 | 1918 | 0.010 |
Why?
|
California | 1 | 2004 | 1402 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12744 | 0.010 |
Why?
|
Hospitalization | 1 | 1999 | 10259 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1653 | 0.010 |
Why?
|
China | 1 | 2004 | 2243 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1992 | 7719 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23327 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2002 | 1101 | 0.010 |
Why?
|
Genes, jun | 1 | 1994 | 71 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2002 | 2712 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23398 | 0.010 |
Why?
|
Genes, fos | 1 | 1994 | 183 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 12066 | 0.010 |
Why?
|
Genes, myc | 1 | 1994 | 399 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2950 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6934 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35122 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 40964 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3229 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1783 | 0.010 |
Why?
|
Smoking | 1 | 2005 | 8984 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 12798 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5867 | 0.000 |
Why?
|
Protein Binding | 1 | 1995 | 9377 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 18107 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1994 | 11478 | 0.000 |
Why?
|